Bryan E-Xin Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bryan E-Xin Tan has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Bipul Baibhav
7 shared publicationsMohan Rao
Sands‐Constellation Heart Institute Rochester Regional Health Rochester New York USA
5 shared publications- Deepak L. Bhatt
Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY (D.L.B.).
4 shared publications - Jeremiah Peter Depta
Rochester Regional Health
4 shared publications - Leela Krishna Teja Boppana
Pulmonary/Critical care, University of Florida, College of Medicine-Jacksonville, Jacksonville, Florida, USA
4 shared publications - Samarthkumar Thakkar
Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
4 shared publications
Latest Publications
- 1 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (8) , e018151
Cardiac CT Versus Transesophageal Echocardiography Following Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis
BACKGROUND: In the landmark WATCHMAN trials, transesophageal echocardiography (TEE) was used to evaluate peri-device leak (PDL) and device-related thrombus (DRT) after percutaneous left atrial appendage closure (LAAC). We aimed to investigate the diagnostic utility of cardiac computed tomography angiography (CCTA) compared with TEE for post-LAAC device surveillance. METHODS: We conducted a literature search of 5 electronic databases to identify studies that included patients who underwent both CCTA and TEE after LAAC. We performed a meta-analysis by pooling outcomes for residual leak (left atrial appendage patency), any PDL, large PDL (>5 mm), and DRT. RESULTS: We included 17 cohort studies with 1313 patients who underwent both CCTA and TEE after LAAC. CCTA was associated with higher odds of detecting residual leak (58.8% versus 34.6%, odds ratio, 2.26 [95% CI, 1.48–3.44], P =0.0002; I 2 =73%; 15 studies, 975 patients; moderate certainty) and any PDL (51.6% versus 35.5%, odds ratio, 1.59 [95% CI, 1.01–2.51], P =0.04; I 2 =73%; 12 studies, 870 patients; moderate certainty) when compared with TEE. There were no significant differences in the detection rates of large PDL (>5 mm) between CCTA and TEE (2.8% versus 0.8%, odds ratio, 3.12 [95% CI, 0.73–13.36], P =0.13; I 2 =0%; 5 studies, 338 patients; moderate certainty). The incidence of DRT was low (1.7%), and the detection rate did not differ between the 2 modalities (1.7% versus 1.7%, odds ratio, 1.0 [95% CI, 0.41–2.42], P =1.0; I 2 =0%; 6 studies, 584 patients; high-certainty). CONCLUSIONS: Following LAAC, CCTA had higher odds of detecting residual leak and any PDL compared with TEE, whereas there were no significant differences in the detection of large PDL (> 5mm) and DRT between the 2 modalities. The findings of this meta-analysis should provide reassurance to patients and clinicians who prefer CCTA over TEE after LAAC. While DRT and left atrial appendage patency with visible PDL are known to be associated with thromboembolism, the clinical significance of left atrial appendage patency without visible PDL is uncertain and warrants further investigation. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42024578802.
- 1 August 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (8) , e018151
Cardiac CT Versus Transesophageal Echocardiography Following Left Atrial Appendage Closure: A Systematic Review and Meta-Analysis
BACKGROUND: In the landmark WATCHMAN trials, transesophageal echocardiography (TEE) was used to evaluate peri-device leak (PDL) and device-related thrombus (DRT) after percutaneous left atrial appendage closure (LAAC). We aimed to investigate the diagnostic utility of cardiac computed tomography angiography (CCTA) compared with TEE for post-LAAC device surveillance. METHODS: We conducted a literature search of 5 electronic databases to identify studies that included patients who underwent both CCTA and TEE after LAAC. We performed a meta-analysis by pooling outcomes for residual leak (left atrial appendage patency), any PDL, large PDL (>5 mm), and DRT. RESULTS: We included 17 cohort studies with 1313 patients who underwent both CCTA and TEE after LAAC. CCTA was associated with higher odds of detecting residual leak (58.8% versus 34.6%, odds ratio, 2.26 [95% CI, 1.48–3.44], P =0.0002; I 2 =73%; 15 studies, 975 patients; moderate certainty) and any PDL (51.6% versus 35.5%, odds ratio, 1.59 [95% CI, 1.01–2.51], P =0.04; I 2 =73%; 12 studies, 870 patients; moderate certainty) when compared with TEE. There were no significant differences in the detection rates of large PDL (>5 mm) between CCTA and TEE (2.8% versus 0.8%, odds ratio, 3.12 [95% CI, 0.73–13.36], P =0.13; I 2 =0%; 5 studies, 338 patients; moderate certainty). The incidence of DRT was low (1.7%), and the detection rate did not differ between the 2 modalities (1.7% versus 1.7%, odds ratio, 1.0 [95% CI, 0.41–2.42], P =1.0; I 2 =0%; 6 studies, 584 patients; high-certainty). CONCLUSIONS: Following LAAC, CCTA had higher odds of detecting residual leak and any PDL compared with TEE, whereas there were no significant differences in the detection of large PDL (> 5mm) and DRT between the 2 modalities. The findings of this meta-analysis should provide reassurance to patients and clinicians who prefer CCTA over TEE after LAAC. While DRT and left atrial appendage patency with visible PDL are known to be associated with thromboembolism, the clinical significance of left atrial appendage patency without visible PDL is uncertain and warrants further investigation. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42024578802.
- Open Access
- 1 January 2024
- Published by XMLink in International Journal of Heart Failure
- Vol. 6 (2) , 76-81
Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE)
Tan MC, et al. Int J Heart Fail. 2023 Sep;5:e23. https://doi.org/10.36628/ijhf.2023.0020
- 1 January 2024
- Published by XMLink in International Journal of Heart Failure
- Vol. 6 (2) , 76-81
Open AccessAdverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE)
Tan MC, et al. Int J Heart Fail. 2023 Sep;5:e23. https://doi.org/10.36628/ijhf.2023.0020
- 12 September 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 102 (5) , 919-928
Utility of rapid atrial pacing before and after TAVR with balloon‐expandable valve in predicting permanent pacemaker implantation
Background: High‐grade or complete atrioventricular block (AVB) requiring permanent pacemaker (PPM) implantation is a known complication of transcatheter aortic valve replacement (TAVR). Wenckebach AVB induced by rapid atrial pacing (RAP) after TAVR was previously demonstrated in an observational analysis to be an independent predictor for PPM. We sought to investigate the utility of both pre‐ and post‐TAVR RAP in predicting PPM implantation.Methods: In a single‐center, prospective study, 421 patients underwent TAVR with balloon‐expandable valves (BEV) between April 2020 and August 2021. Intraprocedural RAP was performed in patients without a pre‐existing pacemaker, atrial fibrillation/flutter, or intraprocedural complete AVB to assess for RAP‐induced Wenckebach AVB. The primary outcome was PPM within 30 days after TAVR.Results: RAP was performed in 253 patients, of whom 91.3% underwent post‐TAVR RAP and 61.2% underwent pre‐TAVR RAP. The overall PPM implantation rate at 30 days was 9.9%. Although there was a numerically higher rate of PPM at 30 days in patients with RAP‐induced Wenckebach AVB, it did not reach statistical significance (13.3% vs. 8.4%, p = 0.23). In a multivariable analysis, RAP‐induced Wenckebach was not an independent predictor for PPM implantation at 30 days after TAVR. PPM rates at 30 days were comparable in patients with or without pre‐TAVR pacing‐induced Wenckebach AVB (11.8% vs. 8.2%, p = 0.51) and post‐TAVR pacing‐induced Wenckebach AVB (10.2% vs. 5.8%, p = 0.25).Conclusion: In patients who underwent TAVR with BEV, there were no statistically significant differences in PPM implantation rates at 30 days regardless of the presence or absence of RAP‐induced Wenckebach AVB. Due to conflicting results between the present study and the prior observational analysis, future studies with larger sample sizes are warranted to determine the role of RAP during TAVR as a risk‐stratification tool for significant AVB requiring PPM after TAVR.
- 12 September 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 102 (5) , 919-928
Utility of rapid atrial pacing before and after TAVR with balloon‐expandable valve in predicting permanent pacemaker implantation
Background: High‐grade or complete atrioventricular block (AVB) requiring permanent pacemaker (PPM) implantation is a known complication of transcatheter aortic valve replacement (TAVR). Wenckebach AVB induced by rapid atrial pacing (RAP) after TAVR was previously demonstrated in an observational analysis to be an independent predictor for PPM. We sought to investigate the utility of both pre‐ and post‐TAVR RAP in predicting PPM implantation.Methods: In a single‐center, prospective study, 421 patients underwent TAVR with balloon‐expandable valves (BEV) between April 2020 and August 2021. Intraprocedural RAP was performed in patients without a pre‐existing pacemaker, atrial fibrillation/flutter, or intraprocedural complete AVB to assess for RAP‐induced Wenckebach AVB. The primary outcome was PPM within 30 days after TAVR.Results: RAP was performed in 253 patients, of whom 91.3% underwent post‐TAVR RAP and 61.2% underwent pre‐TAVR RAP. The overall PPM implantation rate at 30 days was 9.9%. Although there was a numerically higher rate of PPM at 30 days in patients with RAP‐induced Wenckebach AVB, it did not reach statistical significance (13.3% vs. 8.4%, p = 0.23). In a multivariable analysis, RAP‐induced Wenckebach was not an independent predictor for PPM implantation at 30 days after TAVR. PPM rates at 30 days were comparable in patients with or without pre‐TAVR pacing‐induced Wenckebach AVB (11.8% vs. 8.2%, p = 0.51) and post‐TAVR pacing‐induced Wenckebach AVB (10.2% vs. 5.8%, p = 0.25).Conclusion: In patients who underwent TAVR with BEV, there were no statistically significant differences in PPM implantation rates at 30 days regardless of the presence or absence of RAP‐induced Wenckebach AVB. Due to conflicting results between the present study and the prior observational analysis, future studies with larger sample sizes are warranted to determine the role of RAP during TAVR as a risk‐stratification tool for significant AVB requiring PPM after TAVR.
- 5 August 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 181, 122-129
Meta-Analysis of Efficacy of Vasopressin During Cardiopulmonary Resuscitation
- 5 August 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 181, 122-129
Meta-Analysis of Efficacy of Vasopressin During Cardiopulmonary Resuscitation
- 21 July 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (11) , 101335
Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis
- 21 July 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 47 (11) , 101335
Direct Oral Anticoagulant Versus Warfarin After Left Atrial Appendage Closure With WATCHMAN: Updated Systematic Review and Meta-analysis
- Open Access
- 20 April 2022
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 1 (3)
Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin Following WATCHMAN in High-Risk Patients
- 20 April 2022
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 1 (3)
Open AccessSafety and Efficacy of Direct Oral Anticoagulants Versus Warfarin Following WATCHMAN in High-Risk Patients
- 24 March 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 48 (8) , 101174
Clopidogrel Vs Aspirin Monotherapy Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
- 24 March 2022
- Published by Elsevier in Current Problems in Cardiology
- Vol. 48 (8) , 101174
Clopidogrel Vs Aspirin Monotherapy Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
- 7 February 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (5) , 1636-1644
Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database
Background: There is a paucity of data regarding the sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement (TS‐TMVR).Methods: The Nationwide Readmissions Database (2015–2018) was queried for admissions for TS‐TMVR. Propensity matched analysis was conducted to compare outcomes with hospitalizations for TS‐TMVR among women versus men. The main study outcome was in‐hospital mortality.Results: Our final analysis included 2063 hospitalizations for TS‐TMVR; of whom, 58.1% were women. The proportion of women among those undergoing TS‐TMVR increased from 50% in 2015 to 60.2% in 2018 (Ptrend = 0.04). Compared with men, women undergoing TS‐TMVR were slightly younger, and had a distinct profile of comorbidities. After matching, there was no significant difference in in‐hospital mortality among women versus men undergoing TS‐TMVR (7.8% vs. 6.1%, OR = 1.30; 95% CI: 0.79–2.13). Subgroup analyzes showed an interaction toward higher mortality with women versus men among patients with CKD (Pinteraction = 0.07). There were no significant differences between women and men in in‐hospital complications or length of stay after TS‐TMVR. Compared with men, women undergoing TS‐TMVR were more likely to be discharged to a nursing facility (17.7% vs. 11.5%, p = 0.01) and had higher rates of 30‐day readmissions (22.4% vs. 13.6%, p = 0.01).Conclusion: This nationwide analysis showed an increase in the proportion of women among patients undergoing TS‐TMVR during the study years. There were no differences in in‐hospital mortality, in‐hospital complications, or length of stay between both sexes following TS‐TMVR. Women were more likely to be discharged to nursing facilities and had higher rates of readmission at 30 days even after propensity matching.
- 7 February 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 99 (5) , 1636-1644
Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database
Background: There is a paucity of data regarding the sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement (TS‐TMVR).Methods: The Nationwide Readmissions Database (2015–2018) was queried for admissions for TS‐TMVR. Propensity matched analysis was conducted to compare outcomes with hospitalizations for TS‐TMVR among women versus men. The main study outcome was in‐hospital mortality.Results: Our final analysis included 2063 hospitalizations for TS‐TMVR; of whom, 58.1% were women. The proportion of women among those undergoing TS‐TMVR increased from 50% in 2015 to 60.2% in 2018 (Ptrend = 0.04). Compared with men, women undergoing TS‐TMVR were slightly younger, and had a distinct profile of comorbidities. After matching, there was no significant difference in in‐hospital mortality among women versus men undergoing TS‐TMVR (7.8% vs. 6.1%, OR = 1.30; 95% CI: 0.79–2.13). Subgroup analyzes showed an interaction toward higher mortality with women versus men among patients with CKD (Pinteraction = 0.07). There were no significant differences between women and men in in‐hospital complications or length of stay after TS‐TMVR. Compared with men, women undergoing TS‐TMVR were more likely to be discharged to a nursing facility (17.7% vs. 11.5%, p = 0.01) and had higher rates of 30‐day readmissions (22.4% vs. 13.6%, p = 0.01).Conclusion: This nationwide analysis showed an increase in the proportion of women among patients undergoing TS‐TMVR during the study years. There were no differences in in‐hospital mortality, in‐hospital complications, or length of stay between both sexes following TS‐TMVR. Women were more likely to be discharged to nursing facilities and had higher rates of readmission at 30 days even after propensity matching.
- Open Access
- 26 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21643
Constrictive Pericarditis: An Unusual Presentation of Rheumatoid Vasculitis
We describe a case of rheumatoid vasculitis with an atypical presentation of constrictive pericarditis. A 51-year-old man who was previously admitted for diffuse lymphadenopathy, presented with chest pain and a lower extremity rash. Extensive workup including multimodality imaging, serology tests, and biopsy, resulted in the diagnosis of rheumatoid vasculitis.
- 26 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21643
Open AccessConstrictive Pericarditis: An Unusual Presentation of Rheumatoid Vasculitis
We describe a case of rheumatoid vasculitis with an atypical presentation of constrictive pericarditis. A 51-year-old man who was previously admitted for diffuse lymphadenopathy, presented with chest pain and a lower extremity rash. Extensive workup including multimodality imaging, serology tests, and biopsy, resulted in the diagnosis of rheumatoid vasculitis.